Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of IDA and Azithromycin Co-Administration for NTDs
NCT03676140Phase 3Completed
- Sponsor
- Lihir Medical Centre
- Start
- Oct 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in trachoma, yaws, lymphatic filariasis (LF), scabies, strongyloidiasis, sponsored by Lihir Medical Centre. Started Oct 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
trachomayawslymphatic filariasis (LF)scabiesstrongyloidiasis
Beyond the preview
Go deeper on NCT03676140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676140.